Statistics
Publications
13
Citations
358
H-Index
13
Active since
2019
Belal Haschimi is an author at University of Freiburg specializing in drug discovery, drug analysis, and cannabinoid pharmacology.
Publications per year
2019–2024
13
13
Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE
Arianna Giorgetti, Lukas Mogler, Sebastian Halter et al. · Forensic Toxicology · 2019 · 35 citations · Full text
Impact of legislation on NPS markets in Germany – The rise and fall of 5F‐ADB
Sebastian Halter, Belal Haschimi, Lukas Mogler et al. · Drug Testing and Analysis · 2020 · 30 citations · Full text
1–5 of 13